Conference abstract · 23 Sep 2024
EditorialPublished 2014
Regulatory Practice in Pharmaceutical Industry
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Hitt Sharma, Sameer Parekh and Sunil Shewale PDF Share this article
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 26 Aug 2024
Global Health Policy Challenges: Coordinating Regulatory Standards in the Pharmaceutical Industry
Article · 26 Jun 2024
Ethical Considerations and Regulatory Frameworks for AI in the Pharmaceutical Industry
Opinion · 12 Jan 2024
Informatics Platforms for Regulatory Compliance in the Pharmaceutical Industry
Article · 3 Jan 2024
Demystifying Regulatory Compliance in the Pharmaceutical Industry
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Hitt Sharma”
- BylineArticles whose byline prints “Sameer Parekh”
- BylineArticles whose byline prints “Sunil Shewale”

